13th International Congress on Infectious Diseases Abstracts, Poster Presentations the bacteria grown in iron deficit medium. This suggests that the outer membrane protein also plays an important role in carbapenem resistance in Acinetobacter spp.
Background: Nontyphoid Salmonella infections are rampant in Asia but there has been no large scale collaborative study to evaluate the serotype distribution and antimicrobial susceptibility in this region.
Methods: Clinical isolates of nontyphoid Salmonella were collected from clinical specimens from 11 medical centers in 7 Asian countries from 2003 to 2005. Broth microdilution method was performed to determine the minimum inhibitory concentrations of 6 antimicrobial agents.
Results: A total of 400 clinical isolates were collected from Hong Kong, Korea, Philippines, Singapore, Sri Lanka, Taiwan, and Thailand. The overall susceptibility was higher to ceftriaxone (97%) and ciprofloxacin (95.5%) than to traditional antibiotics (chloramphenicol, 72.3%; trimethoprim/sulphamethoxazole, 71%; ampicillin, 65.5%; and tetracycline, 54.3%). Among these countries, isolates from Taiwan and Thailand showed higher resistance to each of the 4 traditional antibiotics (all p < 0.001), and those from Korea showed higher resistance to ciprofloxacin (13.5% vs 3.2%; p = 0.004). The multidrug-resistant rate (MDR) was significantly higher in isolates belonging to serogroups B (49.6%) and C1 (46.9%) than other serogroups (all p < 0.004). MDR was common in S. Heidelberg (100%), S. Panama (87.5%), S. Virchow (87.5%), S. Choleraesuis (85.7%), and S. Typhimurium (54.4%). High rates of reduced susceptibility to ciprofloxacin (MIC= 0.125-1 mg/L) were found in isolates from Taiwan (48.2%), Thailand (46.2%) and Korea (36.5%), especially in S. Choleraesuis (68.8%) and S. Virchow (75%). Overall decreased susceptibility to ceftriaxone (MIC>2 mg/L) remained low except isolates from Taiwan (40.7%) or isolates of S. Typhimurium (28.6%) and S. Panama (25%).
Conclusion: Ceftriaxone appears to be drug of choice in the treatment of invasive nontyphoid Salmonella infections. High rate of reduced susceptibility to ciprofloxacin in some Asian countries as well as in some Salmonella serotypes is a concern. Prudent use of antibiotics in both humans and food animals should never be overemphasized. 
